Nonoperating Income (Expense) in USD of ABVC BIOPHARMA, INC. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
ABVC BIOPHARMA, INC. quarterly/annual Nonoperating Income (Expense) history and change rate from 2011 to Q3 2025.
  • ABVC BIOPHARMA, INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$119K, a 35.8% increase year-over-year.
  • ABVC BIOPHARMA, INC. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$476K, a 18.7% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Nonoperating Income (Expense) for 2024 was -$664K, a 47.2% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Nonoperating Income (Expense) for 2023 was -$1.26M, a 214% decline from 2022.
  • ABVC BIOPHARMA, INC. annual Nonoperating Income (Expense) for 2022 was -$400K, a 181% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$476K -$119K +$66.2K +35.8% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 -$542K -$14.2K +$284K +95.2% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 -$826K -$251K -$162K -181% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 -$664K -$92K -$78.8K -599% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$586K -$185K +$1.03M +84.8% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025
Q2 2024 -$1.61M -$298K -$259K -651% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$1.36M -$89.4K -$98.4K -1099% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 -$1.26M -$13.2K 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$1.21M 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$39.7K 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $8.95K +$18.4K 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q1 2022 $415K -$9.41K -$80.4K -113% 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $495K $493K +$697K 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2022
Q3 2021 -$202K $8.64K +$895K 01 Jul 2021 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 -$1.1M -$77K +$962K +92.6% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 -$2.06M $71K +$249K 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$2.31M -$205K -$186K -964% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$2.12M -$886K -$721K -435% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$1.4M -$1.04M -$872K -524% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$530K -$178K +$21.8K +10.9% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 -$552K -$19.3K +$2.84M +99.3% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 -$3.4M -$166K +$195K +54% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020
Q2 2019 -$3.59M -$166K +$122K +42.3% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$3.71M -$200K -$66.6K -49.8% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q4 2018 -$3.65M -$2.86M -$2.83M -9973% 01 Oct 2018 31 Dec 2018 10-K 15 May 2020
Q3 2018 -$811K -$360K -$333K -1211% 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019
Q2 2018 -$478K -$288K -$260K -916% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$218K -$134K -$115K -604% 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019
Q4 2017 -$103K -$28.4K -$28.5K 01 Oct 2017 31 Dec 2017 10-KT 13 Apr 2018
Q3 2017 -$74.8K -$27.5K +$31.1K +53.1% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$106K -$28.4K -$25.1K -760% 01 Apr 2017 30 Jun 2017 10-Q 20 Aug 2018
Q1 2017 -$80.8K -$19K -$71K -137% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$9.81K $49.00* -$143 01 Oct 2016 31 Dec 2016 10-KT 13 Apr 2018
Q3 2016 -$9.67K -$58.6K 01 Jul 2016 30 Sep 2016 10-KT 13 Apr 2018
Q2 2016 -$3.3K -$3.3K 01 Apr 2016 30 Jun 2016 10-Q 19 Mar 2018
Q1 2016 $52K +$52K 01 Jan 2016 31 Mar 2016 10-Q/A 19 Mar 2018
Q4 2015 $192 +$192 01 Oct 2015 31 Dec 2015 10-Q/A 19 Mar 2018
Q2 2015 $0 $0 01 Apr 2015 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 $0 $0 01 Jan 2015 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 $0 $0 01 Oct 2014 31 Dec 2014 10-Q 23 Feb 2016
Q2 2014 $0 $0 +$16.5K 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 -$16.5K $0 +$16.2K 01 Jan 2014 31 Mar 2014 10-Q 05 Jun 2015
Q4 2013 -$32.7K $0 +$16.4K 01 Oct 2013 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 -$49.1K $0 +$14.9K 01 Jul 2013 30 Sep 2013 10-K 16 Apr 2015
Q2 2013 -$64K -$16.5K -$3.04K -22.5% 01 Apr 2013 30 Jun 2013 10-Q 17 Apr 2015
Q1 2013 -$61K -$16.2K -$3.9K -31.7% 01 Jan 2013 31 Mar 2013 10-Q 17 Apr 2015
Q4 2012 -$57.1K -$16.4K -$198K -109% 01 Oct 2012 31 Dec 2012 10-Q 17 Apr 2015
Q3 2012 $141K -$14.9K 01 Jul 2012 30 Sep 2012 10-K 16 Apr 2015
Q2 2012 -$13.5K 01 Apr 2012 30 Jun 2012 10-Q 16 Apr 2015
Q1 2012 -$12.3K 01 Jan 2012 31 Mar 2012 10-Q 16 Apr 2015
Q4 2011 $182K 01 Oct 2011 31 Dec 2011 10-Q 16 Apr 2015

ABVC BIOPHARMA, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$664K +$594K +47.2% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$1.26M -$858K -214% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$400K -$895K -181% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 $495K +$2.8M 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2022
2020 -$2.31M -$1.76M -319% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$552K +$3.09M +84.9% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$3.65M -$3.54M -3429% 01 Jan 2018 31 Dec 2018 10-K 15 May 2020
2017 -$103K -$93.6K -968% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 -$9.67K 01 Oct 2015 30 Sep 2016 10-KT 13 Apr 2018
2013 -$49.1K -$190K -135% 01 Oct 2012 30 Sep 2013 10-K 16 Apr 2015
2012 $141K -$528K -78.9% 01 Oct 2011 30 Sep 2012 10-K 16 Apr 2015
2011 $669K 01 Oct 2010 30 Sep 2011 10-K 15 Apr 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.